No article text was recorded for this version.
rule-based dose escalation
Version 1 of 146 papers59 conceptsfrozen 2026-10-04
Papers in this version
- Blog: First-in-Human Phase I Clinical Trial of SLC-391, a Novel and Selective AXL Inhibitor, in Patients with Advanced Solid Tumours
- Blog: Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial
- Blog: A new function for drug combination dose finding trials
- Blog: Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)
- Blog: A nonparametric Bayesian continual reassessment method in single-agent dose-finding studies
- Blog: First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid Malignancies
- Blog: OC 8582 A PHASE IA/B STUDY TO ASSESS SAFETY AND IMMUNOGENICITY OF PLACENTAL MALARIA VACCINE CANDIDATE: PRELIMINARY RESULTS OF THE PRIMALVAC TRIAL
- Blog: Atropine as an Adjunct in the Management of Pediatric Patients With Hypertrophic Pyloric Stenosis: A Single Institution Experience and Review of the Literature
- Blog: Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT)
- Blog: A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome
- Blog: Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer
- Blog: A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer
- Blog: Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
- Blog: Retrospective Analysis of Sacubitril/Valsartan vs Benazepril for Treating Heart Failure Following Acute Myocardial Infarction
- Blog: Use of Tocilizumab to Treat Arthritis Associated with Mixed Connective Tissue Disease Complicated by Ovarian Teratoma: A Case Report
- Blog: Safety and Efficacy of Multiple Escalating Doses of RC28-E for Neovascular Age-Related Macular Degeneration: A Phase 1b Trial
- Blog: Clinical Observation of Extensively Hydrolysis Protein Formula With Feeding Intolerance in Preterm Infants
- Blog: First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors
- Blog: Trial of an Anti-inflammatory Agent (Indomethacin) in Low Back Pain with and without Radicular Involvement
- Blog: A Triple Therapeutic Regiment Consisted of Colchicine, Thalidomide and Total Glucosides of Paeony Is Effective and Well‐Tolerated for Treating Mucocutaneous Involvement in Patients With Behcet's Disease
- Blog: A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
- Blog: Safety, pharmacokinetics, and efficacy of abexinostat, an novel histone deacetylase inhibitor, in Chinese patients with relapsed/refractory B cell non-Hodgkin lymphoma: a Phase 1 study
- Blog: Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors
- Blog: Assessment of Efficacy and Safety of Haloxazolam in Psychiatric Patients with Insomnia
- Blog: Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
- Blog: HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial
- Blog: Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up
- Blog: In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [11C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates
- Blog: Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC)
- Blog: GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- Blog: Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients with Essential Hypertension: A Phase III, Multicenter, Double-Blind, Parallel-Group, Randomised study
- Blog: The research of human umbilical cord mesenchymal stem cells therapy in decompensated liver cirrhosis associated with hepatitis virus B: a long-term follow up analysis of a single-center, on-limits and stepped research.
- Blog: STUDY OF ZNO NANOPARTICLES ON THYROID HORMONES, TESTOSTERONE LEVEL AND TESTES HISTOLOGY
- Blog: Survival patterns after perioperative treatment escalation and cystectomy for synchronous oligometastatic bladder cancer (M1a/M1b) – a population-based series
- Blog: Pharmacokinetics, safety and tolerability of L-3-n-butylphthalide tablet after single and multiple oral administrations in healthy Chinese volunteers
- Blog: A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients
- Blog: Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
- Blog: Estimation of median effective doses and 95% effective doses of oliceridine combined with propofol for day-case hysteroscopy under total intravenous anesthesia with preserved spontaneous breathing: an up-and-down sequential allocation trial
- Blog: Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer
- Blog: A Phase I Dose-Escalation Study of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Oral Dose of Tigulixostat
- Blog: Phase I clinical trial of NH130 and the prediction of its pharmacokinetics using physiologically based pharmacokinetic modeling
- Blog: A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS
- Blog: Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial
- Blog: A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours
- Blog: Effect of memantine combined with citalopram on cognition of BPSD and moderate Alzheimer's disease: A clinical trial
- Blog: Pulsed Dye Laser for Port Wine Stains in 974 Children: A 20-Year Study in China
History & citation
Current · Permanent link
- Finding the Optimal Therapeutic Window Through Systematic Titration merged into this direction (57% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_rule_based_dose_escalation_5cac65e5,
title = {rule-based dose escalation},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/rule-based-dose-escalation/rdr_5cac65e59df04eaeacd27abd6031a1e3},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_rule_based_dose_escalation_5cac65e5_v1,
title = {rule-based dose escalation},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/rule-based-dose-escalation/rdr_5cac65e59df04eaeacd27abd6031a1e3/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}